Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...

Candida auris is a dangerous fungal pathogen that has become a global health concern. It spreads easily in health care settings and can cause life-threatening infections, especially in patients with ...

Mechanism of action describes the process by which a molecule, such as a drug, functions to produce a pharmacological effect. A drug’s mechanism of action may refer to its effects on a ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

Natural products are essential sources of bioactive compounds for drug discovery. While earlier drug development relied on targeting single molecules to ...

Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...

Candida, a type of fungus, can spread throughout the body via the bloodstream, leading to organ damage and sepsis. Recently, ...

Find latest legal news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

The Prescription Drug User Fee Act typically calls for a period of 10 months for the FDA to review such applications, although drugs that are deemed a priority have a review period of six months.

Biomedical literature lacks integration of dynamic drug interaction data for personalized prescriptions. This proposed work is a new hybrid model that enhances drug safety prescriptions by taking into ...

At present, no drugs related to brain protection have received strong recommendations from the guidelines in the treatment of stroke. Given the increasing understanding of the interactions between the ...